Liminal Biosciences Inc (DELISTED) (LMNL:DL)
8.50
USD |
NASDAQ |
Sep 25, 15:59
Liminal Biosciences Debt to Equity Ratio: 0.00 for June 30, 2023
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Grace Therapeutics, Inc. | 0.00 |
| Aurinia Pharmaceuticals, Inc. | 0.2138 |
| Edesa Biotech, Inc. | 0.00 |
| Lexaria Bioscience Corp. | 0.0366 |
| Xenon Pharmaceuticals, Inc. | 0.0149 |
Debt to Equity Ratio Related Metrics
| Current Ratio | 2.775 |